Abstract:The aim of the present study was to investigate the relative bioavailability and bioequivalence of a new tablet formulation of metformin hydrochloride with reference to a standard product in healthy Chinese adult male volunteers. Two randomized, comparative, two-way crossover studies were therefore conducted. In study 1, which was a single-dose study, 20 subjects received 1000 mg metformin hydrochloride lest product extended-release (MXR) tablets followed by the same amount of metformin hydrochloride reference product immediate-release (MIR) tablets with a 7-day washout period between the two doses. In study 2, which was a multiple-dose study, 22 subjects received MXR 1000 mg/d for 9 consecutive days followed by MIR 1000 mg/d with a 14-day washout period between the doses of the test and reference product. The serum metformin concentrations were monitored using a selective and sensitive high-performance liquid chromatography (HPLC) method with ultraviolet (UV) detection. The pharmacokinetic parameters were calculated using a 3P97 program. Analysis of variance (ANOVA) of the half-life of the absorption phase (t1/2ka), the half-life of the elimination phase (t1/2kc) and the mean retention time (MRT) and the Wilcoxon Signed Rank test of Tmax for the two preparations were significantly different. A significant difference was found in the ANOVA for Cmax in the single-dose study, while this was not the case in the multiple-dose study. Two one-sided t-tests showed that there were no significant differences in the area under the concentration-time curve (AUC) values between the two formulations. The present study indicates that the test preparation was bioequivalent to the reference preparation when both MXR and MIR were investigated in healthy Chinese adult male volunteers. And on the basis of the mean AUC0−t, AUC0−∞ and AUCss, the relative bioavailability of the MXR was found to be 107.80%, 111.89% and 110.61% respectively compared with MIR.

Study on the release property and relative bioavailability of sustained-release magnesium chloride tablet

Compound Magaldrate Chewable Tablets in Treatment of Symptoms of Gastric Acid-Related Diseases: a Multicenter, Randomized, Double-Blind, Double-Dummy, Controlled Trial

Study on Correlation Between in vitro Release and in vivo Absorption of Captopril Delayed-onset, Sustained Release Tablet

Relative bioavailability of disodium etidronate capsules in healthy volunteers

Study on Correlation Between {\sl in Vitro} Release and {\sl in Vivo} Absorption of Captopril Delayed--onset, Sustained Release Tablet

Study on pramipexole dihydrochloride sustained-release tablets

Study on bioequivalence of cilostazol table in healthy volunteers

Relative Bioavailability and Bioequivalence of Metforphin Hydrochloride Extended-Released and Immediate-Released Tablets in Healthy Chinese Volunteers

Bioequivalence of Clarithromycin Dispersed Tablet in Health Volunteers

Study on preparation and slow release properties of Magnesium-Al hydrotalcite with alanine intercalation

Bioavailability Evaluation of Sustained-Release Metformin Formulation after Single and Multiple Oral Dosing in Healthy Volunteers

Pharmacokinetic and bioequivalence studies of trospium chloride after a single-dose administration in healthy Chinese volunteers.

Pharmacokinetics and Bioequivalence Study of Cefixime Tablet in Healthy Volunteers

Bioequivalence evaluation of domestic tablets and imported capsules of rivastigmine tartrate

Bioequivalence of erythromycin ethylsuccinate orally disintegrating tablet in healthy volunteers

Bioequivalence Study of Aspirin Sustained-release Capsules in Healthy Volunteers

Pharmacokinetic Study of Docetaxel after Intravenous Administration of Magnesium Isoglycyrrhizinate Injection in Rats by UPLC-MS-MS

A Comparative Bioavailability Study of Carbamazepine Tablets and a Chewable Tablet Formulation

Bioavailability and Pharmacokinetics of Two Sustained Release Formulations of Mizolastine in Healthy Volunteers

Pharmacokinetics and Bioequivalence of Etodolac Sustained Released Tablets in Healthy Volunteers

Study of pharmacokinetics and LC-MS/MS method of blood concentration of methyclothiazide